The effect of ranolazine was analyzed in two experimental models of heart failure, i.e. 10 month-old B6 mice with 6 months of chronic pressure overload and 18 month-old ApoE-/- mice with advanced atherosclerosis. Here, APOE is linked to atherosclerosis.